SGO survey offers snapshot of gynecologic oncology

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 19 No 7
Volume 19
Issue 7

The Society of Gynecologic Oncologists conducted a demographic and practice survey and found that their members are shifting away from private practice into salaried positions. The survey also found an increase in the number of group or multispecialty practices.

The Society of Gynecologic Oncologists conducted a demographic and practice survey and found that their members are shifting away from private practice into salaried positions. The survey also found an increase in the number of group or multispecialty practices.

"Gynecologic Oncology 2010: State of the Subspecialty" looked at changes in practice characteristics and patterns, workload activities, and liability. The survey can be obtained at www.sgo.org.

"The ability to compare and contrast the subspecialty's current climate with that of five years ago gives our profession a concrete idea to the trends in women's cancer care," said Daniel Clarke-Pearson, MD, SGO president. "The study's findings offer a real indication of practice workforce needs, what is required of today's gynecologic oncologist, and a road map for where the profession is heading in the future."

In other news, the society has published the third installment in its four-part series on cervical cancer. The white paper, entitled "Can the Barriers to HPV Vaccination in High-Risk Populations be Overcome?" identified populations of U.S. women at high risk for cervical cancer and evaluated the known reasons for existing outcomes disparities.

Recent Videos
A prospective trial may help affirm ctDNA as a non-invasive option of predicting responses to radiotherapy among those with gynecologic cancers.
ctDNA reductions or clearance also appeared to correlate with a decrease in disease burden during the pre-boost phase of radiotherapy.
Investigators evaluated ctDNA as a potentially noninvasive method to predict response to radiotherapy among those with gynecologic malignancies.
The Foundation for Women’s Cancer provides multicultural resources for patients with gynecologic cancers to help address gaps in care.
Ginger J. Gardner, MD, FACOG, addresses the growing uterine cancer cases among patients in the United States and the need for greater genetic testing.
Ginger J. Gardner, MD, FACOG, discussed the state of gynecologic cancers and her role in empowering research, education, and awareness surrounding them.
Brian Slomovitz, MD, MS, FACOG discusses the use of new antibody drug conjugates for treating patients with various gynecologic cancers.
Developing novel regimens may continue to improve survival outcomes of patients with advanced cervical cancer following the FDA approval of pembrolizumab and chemoradiation, says Jyoti S. Mayadev, MD.
Related Content